南新制药
(688189)
| 流通市值：19.07亿 | | | 总市值：19.07亿 |
| 流通股本：2.74亿 | | | 总股本：2.74亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 665,760,897.54 | 501,891,678.69 | 621,795,727.5 | 757,153,421.15 |
| 应收票据及应收账款 | 559,906,023.28 | 634,192,728.41 | 652,947,625.14 | 777,966,703.04 |
| 其中：应收票据 | 15,944,236.8 | - | 600,886.55 | 113,107,732.23 |
| 应收账款 | 543,961,786.48 | 634,192,728.41 | 652,346,738.59 | 664,858,970.81 |
| 应收款项融资 | 27,128,199.72 | 3,130,160.8 | 54,426,990.43 | - |
| 预付款项 | 5,270,459.01 | 28,878,161.11 | 29,832,291.41 | 47,528,972.07 |
| 其他应收款合计 | 947,489.93 | 3,846,037.26 | 10,879,700.04 | 6,952,458.89 |
| 其中:应收利息 | - | - | 4,508,675.8 | 4,575,153.47 |
| 存货 | 28,416,002.16 | 56,545,098.3 | 45,768,398.59 | 39,520,200.23 |
| 其他流动资产 | 2,581,955.73 | 3,173,056.56 | 778,205.67 | 2,082,966.83 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,290,011,027.37 | 1,231,656,921.13 | 1,416,428,938.78 | 1,631,204,722.21 |
| 非流动资产: | | | | |
| 固定资产 | 184,895,382.43 | 185,138,428.73 | 190,369,331.71 | 194,792,719.5 |
| 在建工程 | 573,132.07 | 6,190,475.43 | 3,887,560.39 | 239,622.64 |
| 使用权资产 | 1,077,752.27 | 2,412,722.45 | 2,741,799.46 | 3,599,391.57 |
| 无形资产 | 124,284,348.67 | 127,987,419.57 | 131,117,605.61 | 134,574,530.41 |
| 开发支出 | 63,479,606.85 | 50,281,493.64 | 47,973,946.46 | 45,159,795.48 |
| 商誉 | 10,845,017.78 | 10,845,017.78 | 10,845,017.78 | 10,845,017.78 |
| 长期待摊费用 | 712,458.91 | 837,139.23 | 914,322.28 | 991,505.33 |
| 递延所得税资产 | 57,264,660.1 | 61,878,519.82 | 61,614,748.38 | 48,510,108.28 |
| 其他非流动资产 | 4,393,080 | - | 2,082,123.89 | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 447,525,439.08 | 445,571,216.65 | 451,546,455.96 | 438,712,690.99 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,737,536,466.45 | 1,677,228,137.78 | 1,867,975,394.74 | 2,069,917,413.2 |
| 流动负债: | | | | |
| 短期借款 | 322,950,113.81 | 274,017,248.53 | 428,261,026.26 | 576,674,508.2 |
| 应付票据及应付账款 | 39,547,644.6 | 38,055,487.92 | 34,530,144.4 | 42,926,375.28 |
| 应付账款 | 39,547,644.6 | 38,055,487.92 | 34,530,144.4 | 42,926,375.28 |
| 合同负债 | 13,481,060.04 | 3,838,010.2 | 8,106,579.05 | 12,046,447.14 |
| 应付职工薪酬 | 7,067,519.5 | 5,203,836.71 | 4,879,047.36 | 7,753,374.16 |
| 应交税费 | 14,988,220.79 | 1,584,343.9 | 6,537,392.79 | 22,616,896.05 |
| 其他应付款合计 | 26,994,177.35 | 24,855,146.25 | 22,841,430.38 | 37,779,817.83 |
| 一年内到期的非流动负债 | 710,687.48 | 24,433,748.79 | 24,434,819.89 | 50,358,973.14 |
| 其他流动负债 | 3,702,537.81 | - | 1,053,855.28 | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 429,441,961.38 | 371,987,822.3 | 530,644,295.41 | 750,156,391.8 |
| 非流动负债: | | | | |
| 租赁负债 | 936,336.75 | 3,127,706.13 | 3,454,353.02 | 3,779,726.63 |
| 递延收益 | 3,300,000 | 3,375,000 | 3,450,000 | 3,825,000 |
| 递延所得税负债 | 1,531,728.57 | 1,367,481.37 | 1,367,481.37 | 1,420,076.81 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,768,065.32 | 7,870,187.5 | 8,271,834.39 | 9,024,803.44 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 435,210,026.7 | 379,858,009.8 | 538,916,129.8 | 759,181,195.24 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 274,400,000 | 274,400,000 | 274,400,000 | 196,000,000 |
| 资本公积 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 | 1,253,815,514.58 |
| 盈余公积 | 20,100,414.53 | 18,134,709.43 | 18,134,709.43 | 18,134,709.43 |
| 未分配利润 | -151,799,902.51 | -152,935,167.61 | -125,177,488.6 | -141,052,927.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,318,116,026.6 | 1,315,015,056.4 | 1,342,772,735.41 | 1,326,897,296.06 |
| 少数股东权益 | -15,789,586.85 | -17,644,928.42 | -13,713,470.47 | -16,161,078.1 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,302,326,439.75 | 1,297,370,127.98 | 1,329,059,264.94 | 1,310,736,217.96 |
| 负债和股东权益合计 | 1,737,536,466.45 | 1,677,228,137.78 | 1,867,975,394.74 | 2,069,917,413.2 |
| 公告日期 | 2024-03-26 | 2023-10-31 | 2023-08-31 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |